Potluri Vishnu, Harhay Meera N, Wilson F Perry, Bloom Roy D, Reese Peter P
Department of Medicine, Lankenau Medical Center, Wynnewood, Pennsylvania;
Renal-Electrolyte and Hypertension Division, Perelman School of Medicine, Department of Biostatistics and Epidemiology, and.
J Am Soc Nephrol. 2015 May;26(5):1188-94. doi: 10.1681/ASN.2014030302. Epub 2014 Nov 20.
The Organ Procurement and Transplantation Network gives priority in kidney allocation to prior live organ donors who require a kidney transplant. In this study, we analyzed the effect of this policy on facilitating access to transplantation for prior donors who were wait-listed for kidney transplantation in the United States. Using 1:1 propensity score-matching methods, we assembled two matched cohorts. The first cohort consisted of prior organ donors and matched nondonors who were wait-listed during the years 1996-2010. The second cohort consisted of prior organ donors and matched nondonors who underwent deceased donor kidney transplantation. During the study period, there were 385,498 listings for kidney transplantation, 252 of which were prior donors. Most prior donors required dialysis by the time of listing (64% versus 69% among matched candidates; P=0.24). Compared with matched nondonors, prior donors had a higher rate of deceased donor transplant (85% versus 33%; P<0.001) and a lower median time to transplantation (145 versus 1607 days; P<0.001). Prior donors received higher-quality allografts (median kidney donor risk index 0.67 versus 0.90 for nondonors; P<0.001) and experienced lower post-transplant mortality (hazard ratio, 0.19; 95% confidence interval, 0.08 to 0.46; P<0.001) than matched nondonors. In conclusion, these data suggest that prior organ donors experience brief waiting time for kidney transplant and receive excellent-quality kidneys, but most need pretransplant dialysis. Individuals who are considering live organ donation should be provided with this information because this allocation priority will remain in place under the new US kidney allocation system.
器官获取与移植网络在肾脏分配中优先考虑需要肾移植的既往活体器官捐赠者。在本研究中,我们分析了这一政策对美国等待肾移植的既往捐赠者获得移植机会的影响。我们使用1:1倾向评分匹配方法,组建了两个匹配队列。第一个队列由1996年至2010年期间等待肾移植的既往器官捐赠者和匹配的非捐赠者组成。第二个队列由接受了 deceased 捐赠者肾移植的既往器官捐赠者和匹配的非捐赠者组成。在研究期间,共有385,498例肾移植等待名单,其中252例为既往捐赠者。大多数既往捐赠者在列入名单时需要透析(匹配候选人中分别为64%和69%;P = 0.24)。与匹配的非捐赠者相比,既往捐赠者接受 deceased 捐赠者移植的比例更高(85%对33%;P < 0.001),移植的中位时间更短(145天对1607天;P < 0.001)。既往捐赠者接受的同种异体移植物质量更高(肾捐赠者风险指数中位数,既往捐赠者为0.67,非捐赠者为0.90;P < 0.001),且移植后死亡率低于匹配的非捐赠者(风险比,0.19;95%置信区间,0.08至0.46;P < 0.001)。总之,这些数据表明,既往器官捐赠者肾移植等待时间短,接受的肾脏质量优良,但大多数需要移植前透析。应向考虑活体器官捐赠的个人提供此信息,因为在美国新的肾脏分配系统下,这种分配优先权将继续存在。